Curtis Bamber is a biopharma commercial leader and marketer with extensive experience in strategic leadership, therapeutic insights, and diverse markets. They have successfully led numerous launches in therapeutic areas such as hepatitis C and biosimilars, including the first infliximab biosimilar. From 2010 to 2023, Curtis held key positions at notable companies such as Bristol-Myers Squibb, Hospira, and Pfizer, where they excelled in market access, strategic partnerships, and commercial development. Curtis is currently pursuing a Bachelor of Commerce in Marketing and Finance at the University of Saskatchewan.
Location
Pierrefonds, Canada
This person is not in the org chart
This person is not in any teams